Tamoxifen is a common and important treatment to prevent breast cancer from recurring. A new study shows that variation in a patient’s gut microbiome can impact how effective the treatment is.
A new study has shown that variation in the microbiota of the human gut impacts the pharmacokinetics of tamoxifen and thus the effectiveness of the drug. The finding, published in the journal mBio of ...
The study, published in the journal Gut Microbes, focuses on identifying key microbes within the gut microbiome that inhibit the growth of pathogens ... "Multidrug-resistant microorganisms pose a ...